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Abstract  Rupture  of  an  intracranial  aneurysm  is  a  diagnostic  and  therapeutic  emergency.
Occlusion of  the  aneurysm  with  coils  is  the  ﬁrst  line  treatment  and  should  be  performed
promptly to  avoid  any  further  rupture,  which  carries  a  poor  prognosis.  Most  aneurysms  are
accessible to  this  type  of  treatment.  The  risks  of  coiling,  which  are  mostly  thromboembolic
and less  commonly  hemorrhagic  due  to  peroperative  rupture,  are  low.  The  use  of  stents  or  a
ﬂow diverter  requires  dual  anti-aggregation  which  increases  their  risks  so  that  their  use  are
restricted to  speciﬁc  situations  such  as  dissecting  aneurysms.  Endovascular  treatment  is  effec-
tive in  the  long  and  short  term  prevention  of  recurrent  hemorrhage  provided  that  patients  are
followed up  by  imaging,  which  allows  possible  early  recanalization  to  be  detected  early  and
treated if  necessary.©  2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.Rupture  of  an  intracranial  aneurysm  is  a  diagnostic  and  therapeutic  emergency,  which
requires  multidisciplinary  management  involving  neuroradiologists,  neurosurgeons  and
neurology  intensive  care  physicians  [1].  Occlusion  of  the  aneurysm  is  required  because
of  the  possibility  of  further  rupture.
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Occlusion  of  intracranial  aneurysms  with  controlled
etachment  coils  was  developed  in  1991  [2,3].  This  tech-
ique  has  gradually  overtaken  surgical  clipping  as  the  ﬁrst
ine  management  of  a  ruptured  aneurysm  in  light  of  the
esults  of  the  International  Subarachnoid  Aneurysm  Trial
ISAT),  which  compared  the  two  techniques  [4].
The  indications  for  surgery  are  primarily  limited  to
he  treatment  of  ruptured  aneurysms  causing  compressive
ematomas,  which  need  to  be  evacuated.  The  other  main
ndication,  aneurysms  which  are  not  accessible  to  endovas-
ular  treatment,  is  uncommon.  Technological  advances  such
s  3D  angiography  and  improvements  in  navigation  and
ndovascular  occlusion  materials  have  broadened  the  possi-
ilities  of  endovascular  treatment  (EVT)  to  most  aneurysms.
Basic  EVT  uses  controlled  detachment  coils.  The  use  of
tents  or  ﬂow  diverters  requires  dual  anti-aggregation  which
s  difﬁcult  to  manage  in  the  hemorrhagic  phase  and  is  there-
ore  reserved  for  selective  situations.  Other  more  recent
evices  are  in  clinical  assessment.
This  review  provides  an  update  regarding  the  indications,
echniques,  risks  and  results  of  EVT  for  ruptured  intracranial
neurysms.
ndications
n  untreated  ruptured  aneurysm  is  at  high  risk  of  rebleed-
ng  [5,6].  This  new  rupture  may  occur  very  early  even
efore  the  patient  has  arrived  at  the  hospital,  but  it  usu-
lly  happens  several  days  later.  Risk  increases  over  time
nd  without  intervention  the  cumulative  risk  at  4  weeks  is
0%  [6].
In  addition,  rebleeding  is  associated  with  a  poor  prognosis
nd  high  morbidity  and  mortality  [6].  In  the  ISAT  trial,  59%
f  patients  who  suffered  an  early  rebleed  died  [4].
It  is  therefore  important  to  occlude  the  aneurysm
romptly.  Because  of  the  estimated  risk  of  recurrence  of
.1%  within  24  hours  after  the  initial  rupture,  ultra-early
reatment  of  a  ruptured  aneurysm  has  been  proposed  [7].
ut  on  the  other  hand,  the  advantages  of  this  strategy  are
ontroversial  [8],  particularly  in  view  of  the  increased  risk  of
omplications  during  procedures  performed  in  the  middle  of
he  night,  and  also  because  there  is  currently  no  consensus
n  ultra-early  treatment.  According  to  current  guidelines,
he  aneurysm  should  be  excluded  promptly,  within  72  hours
nd  if  possible  within  48  hours.
The  ISAT  trial  is  the  only  randomized  multicenter  inter-
ational  trial  that  has  compared  surgery  to  endovascular
oiling  for  ruptured  intracranial  aneurysms.  Its  results  sup-
orted  endovascular  treatment  and  showed  a  signiﬁcant
eduction  in  the  risk  of  dependency  or  death  at  1  year  [4],
lthough  the  population  in  this  study  included  a  great  major-
ty  of  young  patients  in  good  clinical  state  (WFNS  grades  1  or
)  [9],  with  anterior  circulation  aneurysms  under  10  mm  in
ize.  The  results  of  this  study  led  to  a  large  and  unrestricted
ncrease  in  endovascular  treatment  for  ruptured  intracra-
ial  aneurysms.  These  results  have  also  been  conﬁrmed
n  other  studies  [10].  Currently,  EVT  is  considered  to  be
he  ﬁrst  line  treatment  for  intracranial  aneurysms  by  most
roups.
Some  sub-populations  of  patients  who  have  suffered  a
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xamined  in  additional  studies.  This  applies  particularly  to
lderly  patients,  aneurysms  with  severe  clinical  grades  and
ompressive  hematomas.
Endovascular  treatment  is  possible  with  acceptable  clin-
cal  results  in  the  elderly.  A  meta-analysis  published  in
013  [11]  showed  high  morbidity  and  mortality  (9%  and  23%
espectively),  although  this  was  related  more  to  the  sever-
ty  of  the  subarachnoid  hemorrhage  and  its  complications
han  to  complications  of  endovascular  treatment  itself  with
 4%  aneurysm  rupture  rate  and  5%  postoperative  ischemic
njuries.  At  1  year,  66%  of  patients  had  recovered  well  or
ad  only  moderate  handicap,  allowing  them  to  be  indepen-
ent  in  their  activities  of  daily  living.  Occlusion  at  1  year
as  complete  or  subtotal  in  87%  of  cases.
Severe  clinical  grade  when  the  patient  is  ﬁrst  managed
WFNS  grade  IV  or  V)  [9],  is  an  independent  poor  progno-
tic  indicator  and  outcome  is  signiﬁcantly  poorer  in  grade  V
atients  [12,13].  Clinical  outcome  was  good  in  62%  of  grade
V  patients  and  in  only  25%  of  grade  V  patients  in  a  series  of
0  patients  by  Bracard  et  al.  [12].
Ruptured  aneurysm  causing  a  compressive  hematoma  is
sually  treated  surgically  by  clipping  the  aneurysm  and
vacuating  the  hematoma  at  the  same  time.  Combined
reatment  with  urgent  coiling  of  the  ruptured  aneurysm
ollowed  by  evacuation  of  the  hematoma  is  an  alternative
reatment  [14].
echniques
VT  is  performed  under  general  anesthesia.  Arterial  access  is
sually  through  the  right  femoral  artery  although  if  endovas-
ular  navigation  is  difﬁcult,  other  approaches  can  be  used:
umeral,  radial  or  even  direct  puncture  of  the  cervical  inter-
al  carotid  artery.  The  access  is  infused  continuously  using
n  introducer  through  which  a  guide  catheter  is  passed
nd  is  positioned  in  the  artery  giving  rise  to  the  aneurysm.
his  artery  has  usually  been  identiﬁed  initially  from  a  CT
ngiogram  performed  at  the  time  of  diagnosis  of  the  sub-
rachnoid  hemorrhage.
A  microcatheter  is  then  carried  by  the  guide  catheter  and
ts  tip  introduced  into  the  aneurysm  using  a  microguide.  The
neurysm  is  occluded  by  gradually  ﬁlling  it  with  decreasing
izes  of  coils  with  the  aim  of  occluding  the  aneurysm  as
ell  as  possible  up  to  its  neck  without  going  beyond  this
Fig.  1).
It is  fundamental  to  treat  the  aneurysm  following  an
ngiographic  view  called  ‘‘working  view’’  which  shows  the
eck  distinctly.  Development  of  3D  angiography  in  1996
layed  an  important  role  in  the  safety  of  an  endovascular
reatment  by  allowing  a  precise  analysis  of  the  morphology
f  the  aneurysm,  facilitating  the  identiﬁcation  of  a  working
iew  and  allowing  the  size  of  the  aneurysm  to  be  measured
ccurately  [15]. The  size  of  the  ﬁrst  coil  must  be  suited  as
ell  as  possible  to  the  size  of  the  aneurysm  in  order  to
btain  a ‘‘frame’’,  which  is  used  as  the  support  structure
o  gradually  ﬁll  the  aneurysm  with  other  coils.
The  quality  of  occlusion  is  assessed  from  an  angiogra-
hy  sequence  at  the  end  of  treatment  in  the  working  view
hich  best  identiﬁes  the  neck  of  the  aneurysm.  Occlusion  is
lassiﬁed  into  3  grades:  total  occlusion,  subtotal  occlusion
r  residual  neck  and  partial  occlusion  or  residual  aneurysm,
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Figure 1. Endovascular treatment (EVT) with coiling of a ruptured aneurysm performed on day 1 of rupture: a: plain cerebral CT shows a
subarachnoid hemorrhage (SAH) in the optic chiasma cistern extending to the motor cortex sulci associated with a ventricular hemorrhage
and dilatation of the lateral ventricles which required an external shunt; b: frontal CT angiography reconstructions showing an aneurysm in
the anterior communicating artery responsible for the SAH; c: 3D angiography of the left internal carotid artery provides an optimal view
which clearly shows the neck of the aneurysm and which is used for EVT for the aneurysm. This is known as the working view; d: accurate
measurements of the dimensions of the aneurysm are taken from the 3D angiogram. These measurements are used to select the size of the
initial coil; e: the working view is reproduced on the angiography arch; f: a microcatheter is advanced under ﬂuoroscopy guidance to the
aneurysm. Its visible tip in the aneurysmal sac is used as a landmark to deploy the coils; g: end of treatment series after inserting 3 coils
showing complete occlusion of the aneurysm; h: the same, unsubtracted series, shows ‘‘packing’’ of coils ﬁtting well to the shape of the
oaneurysm.
total  occlusion  or  a  residual  neck  are  deemed  to  be  satis-
factory.
The  ﬁrst  controlled  detachable  coils  developed  in  1991
were  the  Guglielmi  detachable  coils  (GDC)  [2,3]  and




wf  intracranial  aneurysms  [16]. These  very  ﬂexible  spiral
haped  coils  are  made  of  a  platinum  alloy,  which  is  entirely
ompatible  with  MRI.  A  large  multicenter  series  on  over  700
uptured  aneurysms  treated  by  GDC  [17]  showed  that  coiling
as  feasible  in  96.9%  of  cases  with  a  mortality  rate  of  1.4%
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Figure 2. Endovascular treatment of a wide neck ruptured aneurysm of the basilar artery top using a ‘‘remodeling’’ technique: a:
subarachnoid and intraventricular hemorrhage with ventricular dilatation on CT; b: reconstruction from the 3D angiogram: aneurysm at
the top of the basilar artery with a wide neck extending to the origin of the posterior cerebral arteries; c: working view angiography;
d: unsubtracted angiography after an introduction of a ﬁrst coil using a ‘‘remodeling’’ technique. This technique involves positioning a
protective balloon catheter across the aneurysm neck, and temporarily inﬂating the balloon whilst the coils are positioned avoiding them









































in  particular  large  aneurysms  and  wide  neck,  partial  initialEndovascular  treatment  of  ruptured  intracranial  aneurysms  
and  morbidity  of  8.6%.  The  current  coils  which  are  based
on  the  same  principle  have  undergone  several  technologi-
cal  developments  and  the  user  now  has  a  wide  variety  of
sizes,  3D  shapes  and  ﬂexibilities  which  can  adapt  to  all  types
of  aneurysm.  The  smallest  coils  measure  1  mm  in  diameter
and  the  largest  are  over  20  mm.  New  technological  devel-
opments  have  sought  to  improve  the  effectiveness  of  these
coils  in  terms  of  occlusion.  Coils  with  a  bioactive  coating
have  been  developed  but  have  not  been  shown  to  be  supe-
rior  compared  to  ‘‘uncoated’’  coils  [18].  On  the  other  hand,
the  use  of  coils  incorporating  a  hydrogel  into  their  structure
enabling  them  to  dilate  once  introduced  into  the  aneurysm,
appears  to  reduce  the  risk  of  major  recanalization  [19].
Their  utility  in  preventing  recurrence  of  hemorrhage  and
in  the  long  term  prognosis,  however,  has  not  been  demon-
strated  [19].
When  the  neck  of  the  aneurysm  is  large,  positioning
coils  within  the  aneurysm  can  be  facilitated  by  temporary
inﬂation  using  a  balloon  microcatheter  across  the  neck.
This  technique,  described  by  Moret  et  al.  [20]  under  the
name  ‘‘remodeling’’  technique,  is  widely  used  to  treat  dif-
ﬁcult  aneurysms  safely  [21]  (Fig.  2).  In  addition,  if  the
aneurysm  ruptures,  rapid  inﬂation  of  the  balloon  in  front
of  the  aneurysm  can  limit  the  bleeding  from  rupture  and
improve  prognosis  [22].
The  use  of  stents  as  a  complement  to  coils  requires
long  term  dual  anti-aggregation  because  of  the  very
much  higher  thrombogenic  risk  than  that  of  coils  alone.
Use  of  these  materials  to  treat  ruptured  aneurysms  is
associated  with  a  higher  risk  of  thromboembolic  and  hemor-
rhagic  complications  [23—25]  and  is  therefore  reserved  for
aneurysms  with  a  very  wide  neck  or  with  no  neck  at  all,  such
as  dissecting  aneurysms  and  ‘‘blister  like’’  aneurysms  which
cannot  be  treated  by  coils  alone  or  surgery  (Fig.  3).
‘‘Flow  diverters’’  (FD)  are  self-expanding  stents  devel-
oped  more  recently,  the  very  tight  mesh  of  which  redirects
ﬂow  allowing  the  aneurysm  to  be  occluded  without  using
additional  coils.  These  FD  achieve  high  occlusion  rates  but
require  long-term  dual  anti-aggregation  which  makes  their
use  difﬁcult  in  the  acute  hemorrhagic  phase.  They  can  be
used  in  selected  indications  for  ruptured  aneurysms  such  as
dissecting  aneurysms  and  ‘‘blister  like’’  aneurysms,  which
are  very  small  aneurysms  without  necks  and  are  extremely
fragile  [26,27].  When  possible  and  in  order  to  reduce  the
risks,  these  stents  and  FD  should  be  used  a  few  days  after  the
acute  phase,  possibly  in  addition  to  initial  partial  hemostatic
coiling  carried  out  in  the  acute  phase.
The  ‘‘ﬂow  disrupters’’  are  ﬂexible  intrasaccular  tight
mesh  devices  which  have  been  developed  recently.  A  few
studies  have  shown  that  these  are  suitable  for  treating  com-
plex  aneurysms  of  the  bifurcation  with  a  wide  neck  [28]
including  ruptured  aneurysms  [29]  although  there  is  not  yet




microcatheter has been introduced through the left internal carotid arte
against the wide neck of the aneurysm; e: Subtracted angiography afte
end of treatment angiography, postero-anterior view showing subtotal o
cerebral arteries; g: satisfactory clinical outcome although major reca
treatment with coils and insertion of a stent extending from the superi
The distal markers of the stent can be seen on this unsubtracted image; 
the end of treatment.671
Occlusion  of  the  vessel  containing  the  ruptured  aneurysm
s  a  treatment  option  in  some  rare  situations  such  as  dissec-
ing  aneurysms  of  an  intracranial  vertebral  artery  provided
hat  the  contralateral  vertebral  artery  can  on  its  own
rovide  all  of  the  vertebrobasilar  circulation  [30].  In  this
ype  of  situation,  such  ‘‘deconstructive  techniques’’  are  an
ffective  alternative  to  the  ‘‘constructive’’  techniques  pre-
erving  the  carrier  vessel  using  stents  or  FDs  [31].
isks of EVT
he  two  main  complications  of  EVT  are  thromboembolic
omplications  and  aneurysm  rupture  during  treatment.
A  meta-analysis  published  in  1999  [32]  reported  an
schemic  complication  rate  of  8.5%  with  an  aneurysm  perfo-
ation  rate  of  2.4%  causing  long  term  complications  in  3.7%  of
ases.  More  recently,  a  large  multicenter  prospective  series
33]  has  reported  a  13.3%  thromboembolic  complication
ate  and  3.7%  peroperative  rupture  rate.  As  the  main  risk
s  therefore  thromboembolic  these  treatments  are  usually
arried  out  under  anticoagulation  and/or  with  antiplatelet
gents,  although  there  is  no  consensus  in  literature
34].
esults
n  the  ISAT  trial  [4], the  occlusion  rate  assessed  by  the
perator  was  complete  in  66%  of  cases,  a  residual  neck
as  found  in  26%  of  cases  and  a  residual  aneurysm  in
%.  A  meta-analysis  published  in  2009  [35]  found  similar
esults  with  a 62.3%  complete  occlusion  rate,  29.5%  resid-
al  neck  rate  and  8.2%  residual  aneurysm.  The  CLARITY
‘clinical  and  anatomical  results  in  the  treatment  of  rup-
ured  intracranial  aneurysms’’  multicenter  prospective  trial
n  773  treated  aneurysms  found  slightly  different  ﬁgures:
7.4%  complete  occlusion,  41.9%  residual  neck  and  10.7%
esidual  aneurysm  [36].  The  lower  proportion  of  complete
cclusions  is  explained  by  the  independent  reviewers  which
esignated  a  signiﬁcant  proportion  of  complete  occlusions  as
ssessed  by  the  operator  as  residual  necks  after  occlusion.
he  satisfactory  occlusion  result  combining  partial  occlu-
ions  and  residual  necks  remains,  however,  around  90%  in
hese  different  studies.
One  of  the  limitations  of  treating  aneurysms  is  the  risk
f  recanalization  which  is  greater  after  endovascular  treat-
ent  than  after  surgery  [4,10].  Recanalization  after  coiling
as  many  mechanisms  [37]. The  risk  factors  for  this  arecclusion  and  length  of  follow  up  [38,39]  (Fig.  2).  Recanal-
zation,  however,  may  also  occur  in  aneurysms  completely
ccluded  initially  and  develop  later,  several  years  after
ry via the posterior communicating artery to position it optimally
r positioning 5 coils showing partial occlusion of the aneurysm; f:
cclusion of the aneurysm with preserved patency of the posterior
nalization on the 6 months angiographic follow-up; h: additional
or part of the basilar artery to the right posterior cerebral artery.
i: complete occlusion of the aneurysm on the repeat angiogram at
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Figure 3. Endovascular treatment of a ruptured ‘‘blister’’ aneurysm of the right carotid siphon with a stent and coils; a: 3D angiography:
small ‘‘blister’’ aneurysm without a neck in the usual site at the carotid siphon; b: insertion of coils and a stent in the deployment phase
on this unsubtracted angiography view; c: repeat angiography in the working view at the end of treatment.
Figure 4. Late recurrence of a ruptured anterior communicating artery aneurysm treated 14 years previously by clipping following an
initial rupture, without long term follow up: a: Postero-anterior right carotid angiography: recurrence of aneurysm seen between the 2
surgical clips; b: unsubtracted view showing the position of clips and the craniotomy ﬂap; c: 3D angiography showing the residual aneurysm,
neck and position of the clips; d: working view providing good visualization of the neck; e: complete occlusion of the aneurysm with 4 coils;
f: ﬁnal end of treatment angiogram.
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• Complete  occlusion  or  subtotal  occlusion  with  a
residual  neck  is  deemed  to  be  satisfactory  and  is
achieved  in  approximately  90%  of  cases.
• The  ‘‘remodeling’’  technique  facilitates
endovascular  treatment  of  aneurysms  with  a
wide  neck.
• Stents  and  ﬂow  diverters  have  restricted  indications,
particularly  for  dissecting  aneurysms  and  ‘‘blister’’
aneurysms  which  cannot  be  occluded  by  coils  alone.
• The  risks  of  endovascular  treatment  are  low.  The
two  main  risks  are  thromboembolic  events  and
perioperative  aneurysm  rupture.
• Aneurysms  occluded  by  coils  can  recanalize  and  need
to  be  followed  up  by  imaging.
• Major  recanalizations  and  progressing  residual
aneurysms  require  further  treatment.
• Endovascular  treatment  is  effective  in  preventing
recurrence  of  hemorrhage.  Recurrence  of
hemorrhage  after  endovascular  treatment  is
rare  but  can  occur  late
• These  recurrences  are  due  either  to  recanalization





aneurysms to reduce in-hospital rebleeding and improve clini-
cal outcomes. J Neurosurg 2015;122:383—91.
[8] Consoli A, Grazzini G, Renieri L, Rosi A, De Renzis A, Vig-
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initial  treatment  [38],  justifying  regular  routine  long  term
follow  up.
Recanalization  does  not  systematically  require  further
treatment.  The  indications  for  treatment  vary  depending
on  the  teams  but  are  usually  proposed  for  major  recanal-
ization  or  expanding  residual  aneurysm  on  reviews.  These
‘‘retreatments’’  can  be  carried  out  using  an  endovascu-
lar  approach  or  surgically.  A  systematic  literature  review
found  11.4%  recanalization  rate  and  7.2%  retreatment  rate
in  aneurysms  treated  with  coils  despite  a  95.9%  satisfac-
tory  initial  occlusion  rate  [35].  The  ISAT  trial  reported  more
retreatments  after  coiling  than  after  surgery  [40]  although
the  retreatments  had  no  adverse  consequences  on  clinical
prognosis  [41].
The  primary  aim  of  treating  ruptured  aneurysms  is  to
prevent  the  long  term  risk  of  rebleeding.  The  risk  of  recur-
rent  hemorrhage  is  low  after  both  surgery  and  endovascular
treatment  [41—45],  although  cases  of  late  recurrent  hem-
orrhage  related  to  recanalization  of  the  aneurysm  treated
initially  or  to  rupture  of  de  novo  aneurysms  occurring  sev-
eral  years  after  initial  treatment  have  been  reported  both
following  endovascular  treatment  and  surgery  [45]  (Fig.  4).
Regular  imaging  follow  up  can  detect  these  recanalizations
and  de  novo  aneurysms  at  an  early  stage  and  thereby  reduce
the  risk  of  a  recurrent  bleed.
Conclusion
Endovascular  treatment  is  currently  the  ﬁrst  line  treatment
for  ruptured  intracranial  aneurysms.  The  basic  technique  is
coils  occlusion,  possibly  assisted  by  a  remodeling  balloon.
This  technique  is  appropriate  for  most  aneurysms.  The  use
of  stents  and  ﬂow  diverters  in  the  hemorrhagic  phase  car-
ries  additional  risks,  particularly  through  the  use  of  dual
anti-aggregation  and  is  therefore  reserved  for  those  rare
aneurysms  which  cannot  be  treated  by  coiling  alone.  This
applies  particularly  to  dissecting  aneurysms.  Endovascular
treatment  is  effective  in  the  short  and  long  term  preven-
tion  of  the  risk  of  recurrent  hemorrhage  provided  that  the
aneurysm  occlusion  is  followed  up  by  imaging.  This  allows
investigation  for  possible  recanalization  which  may  require
further  treatment.
Take-home  messages
• Rupture  of  an  intracranial  aneurysm  is  a  diagnostic
and  therapeutic  emergency.
• The  aneurysm  should  be  treated  promptly  to  avoid  a
new  rupture.  The  recommended  time  interval  is  less
than  72  hours,  and  if  possible  less  than  48  hours.
• Endovascular  treatment  is  the  1st line  treatment  for
ruptured  intracranial  aneurysms  and  is  feasible  in
more  than  90%  of  cases.
• Surgery  is  indicated  for  aneurysms  causing  a
compressive  hematoma  and  in  the  occasional  cases
where  endovascular  treatment  is  not  possible.
• Occlusion  with  coils  is  the  most  widely  used
technique  to  occlude  a  ruptured  intracranial
aneurysm.aneurysm  strengthening  the  need  of  imaging  follow
up.
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